¤ë¥Z²¤¶¤Î¤ë¥Z·j´M
³Ì·s¤@´Á(218´Á)
2016¦~(213-217´Á)
2015¦~(201-212´Á)
2014¦~(189-200´Á)
2013¦~(177-188´Á)
2012¦~(165-176´Á)
2011¦~(153-164´Á)
2010¦~(141-152´Á)
2009¦~(129-140´Á)
2008¦~(117-128´Á)
117´Á
118´Á
119´Á
120´Á
121´Á
122´Á
123´Á
124´Á
125´Á
126´Á
127´Á
128´Á
2007¦~(105-116´Á)
2006¦~(093-104´Á)
2005¦~(081-092´Á)
2004¦~(069-080´Á)
2003¦~(057-068´Á)
2002¦~(045-056´Á)
2001¦~(035-044´Á)
2000¦~(031-034´Á)
1999¦~(027-030´Á)
1998¦~(023-026´Á)
1997¦~(018-022´Á)
1996¦~(015-017´Á)
1995¦~(011-014´Á)
1994¦~(007-010´Á)
1993¦~(003-006´Á)
1992¦~(001-002´Á)

 


¡yÀô«O¸ê°T¡z¤ë¥Z²Ä120´Á

Àô¹Ò²üº¸»X»P­¹«~¦w¥þ©Ê¤§Â²¤¶

Àô¹Ò²üº¸»X»P­¹«~¦w¥þ©Ê¤§Â²¤¶

   

®}¿ü¼Ù

°ê¥ß¹Å¸q¤j¾Ç

­¹«~¬ì¾Ç¨tº[¬ã¨s©Ò   ±Ð±Â

¡@

¤@¡B«e¨¥

¦b¬ì¾Ç«ùÄòµo®iªºªÀ·|¸Ì¡A§Ú­Ì©Ò¥Í¬¡ªºÀô¹Ò¥R¥¸µÛ¤j¶qªº¤Æ¾Çª«½è¡C³o¨Ç¤Æ¾Çª«½è«P¶i¤FÁcºa©Mµo®i¡A¤]±aµ¹§Ú­ÌÃe¤jªº§Q¯q¡C¥t¤@¤è­±¡A³o¨Ç¤Æ¾Çª«½èªº¦w¥þ©Ê¤w¸g³y¦¨ªÀ·|¤Wªºª§Ä³¡C¦Û1962¦~Silent Spring(°ê¤º¤¤Ä¶¥»¬°¡u±IÀRªº¬K¤Ñ¡v)©M1996¦~Our Stolen Future(°ê¤º¤¤Ä¶¥»¬°¡u¥¢ÅѪº¥¼¨Ó¢w¥Í©RªºÁô§Î¯E§T¡v)¦¹ÃþªºµÛ§@°Ý¥@¡A¤º®e³¯­z¥ÍºAªº§ïÅܤιï¤HÃþ«áÄòªº¼vÅT¡A³vº¥³ê¿ô¤j²³¹ï©óÀݥΤƾǪ«½è¤§¦M¾÷·NÃÑ¡C¥Ñ©ó¤H­Ì¹ï©ó¤Æ¾Çª«½èªº¨Ï¥Î¡A©¹©¹¥u­«µø¨ã¦³ª½±µ¦M®`¤§¤Æ¾Ç¬r©Êª«½èµ¹¤©ºÞ¨î¡A«o©¿µø¤F¨ä¥L¥i¯à¸g¥Íª«¿@ÁY(Franke et al., 1994)¦Ó²Ö¿n©ó¥Íª«Å餤§@¥Îªº¤Æ¾Çª«½è¡A¹ï©ó¥ÍºA»P¤HÃþªº¼vÅT§ó¬°ÄY­«¡A¬Æ¦Üº×®`¤U¤@¥N¡C

ªñ¦~¨Ó¦U¦¡¦U¼Ëªº¤Æ¾Çª«½è³Q¤j¶q»s³y¨Ï¥Î¡A¨Ã±Æ©ñ¨ìÀô¹Ò¤¤¡C¬Y¨Ç¤Æ¾Çª«½è¡A¨ä¤À¤lµ²ºcªñ¦ü©ó°Êª«Å餺¤Àªc©Ò¥Í²£¤§¿E¯À¡A¤@¥¹¸g¥ÑÀô¹Ò¤¶½è¶i¤J¥Íª«Åé«á¡A§Y·|»P¿E¯À¤§¨üÅé¿ù»~µ²¦X¡A¶i¦Ó±µ¨ü¿ù»~«ü¥O¡A¤zÂZ°Êª«Å餧¥Í²z§@¥Î¡C¤ýµ¥(2000)±N¦¹Ãþ¤Æ¾Çª«½èºÙ¬°¡u¤º¤Àªc¤zÂZª«½è¡v(endocrine disrupter substance, EDS)¡F¬ü°êNational Research CouncilºÙ¤§¬°²üº¸»X¬¡©Êª«½è(hormonally active agents, HAAs)¡F¤é¥»Àô¹ÒÆU«hºÙ¤§¬°Àô¹Ò²üº¸»X(environmental hormones)¡C

¤Ð°ò­f×ô(Nonylphenol¡A²ºÙNP)¤Î¨ä¬ÛÃö¤Æ¾Çª«½è¡A¡u¤Ð°ò­f×ô»E¤A®ñ°ò¾JÃþ(Nonylphenol polyethoxylates¡A²ºÙNPnEO)¡v©M¡u¤Ð°ò­f×ô»E¤A®ñ°òßn»ÄÃþ(Nonylphenol polyethoxy carboxylic acid¡A²ºÙNPnEC)¡v¡A¥D­n¥Î³~¥i§@¬°«DÂ÷¤l¬É­±¬¡©Ê¾¯¡B®a¥Î©Î¤u·~¥Î²M¼ä¾¯¡A©Î²K¥[¦b¯ÈÃþ·í§@¤À´²¾¯(dispersing agents)¨Ï¥Î(Guenther et al., 2002)¡A¥H¤Î¦b¶ì½¦¤¤²K¥[¤T¤Ð­f°òÁC»Äà­( tris-nonylphenol phosphate, TNPP)§@¬°§Ü®ñ¤Æ¾¯(Gilbert et al., 1986)¡C³o¨Ç¤Æ¾Çª«½è¸g¨Ï¥Î«á¡A¨ä¼o²G¤£½×¬O±Æ¤J¦¾¤ô³B²z¼t©Îª½±µ¬y¤J¤ôÅé¡A¬Ò¥i³Q·L¥Íª«¤À¸Ñ¦¨¤Ð°ò­f×ô(Ahel et al., 1993)¡C¨ä¤¤¤Ð°ò­f×ô¤§¤Æ¾Çµ²ºc»P°Êª«ªº»Û©Ê¿E¯Àµ²ºc¬Û¦ü¡A¦]¦¹¦¹Ãþª«½è¤w³QÃҹꬰÀô¹Ò²üº¸»X(Sharpe et al., 1995 )¡A³\¦h¼Ú¬w°ê®a¤w¸g©ú½T¥ßªk³W½d¨ú½l©Î­­¨î¨Ï¥Î¦¹Ãþ¤Æ¾Çª«½è(Jobling et al., 1998 )¡C

¥xÆW¥Ø«e¨C¦~¥Í²£¨Ï¥Î¬ù48,000¤½¾·ªº¤Ð°ò­f×ôÃþ«DÂ÷¤l¬É­±¬¡©Ê¾¯¡F¥Ñ©ó¯Ê¥F®a®x¦Ã¤ô¤Î¤u·~¼o¤ôªº¼o¤ô³B²z¼t¡Aªñ¦~¨Ó¤åÄm«ü¥X¡A¤w±q«Ü¦hªe¤t·Ë¬y¤§¤ôÅé©Mªe¤t¨I¿n©³ªd¸ÌÀËÅç¥X¤Ð°ò­f×ôÃþ¤Æ¦Xª«¤§´Ý¦s¡A¥B¤j³¡¤ÀÀËÅ窺µ²ªG§¡¸û¨ä¥L°ê®a¤§´Ý¯d¿@«×¬°°ª¤§ÁͶÕ(Ding and Tzing, 1998)¡C¤Ð°ò­f×ôÃþ¤Æ¦Xª«¹ï¤ôªº·»¸Ñ«×«D±`§C¡A¦Ó¤A®ñ°ò¾JÃì«h¬°¿Ë¤ô©Ê¡AÀHµÛ¤Ð°ò­f×ôÃþ¤Æ¦Xª«³Qªe¤t©³ªd¤¤¹½®ñ©Ê·L¥Íª«©Ò­°¸Ñ¡A¨ä¥NÁª«ªº¿Ë¯×©Ê«h´£°ª¡A¥Ñ¦¹¤Æ©ÊªºÅã¥Ü¡A¤Ð°ò­f×ôÃþ¤Æ¦Xª«¥NÁª«¥i¯à©ó¥Íª«Å餤²£¥Í¥Íª«¿@ÁY§@¥Î¡C

¥t¥~¡A¤é±`¶¼­¹¤§­¹«~¥i¯à¶¡±µ§t¦³¦¹Ãþ¤Æ¾Çª«½è¡A¥H¤Î¦UºØ¥]¸Ë§÷®Æ¤Î®e¾¹¥ç¥i¯à¦³¤Ð°ò­f×ô¤§·»¥X¡C¦]¦¹¡A¹ï¶¼­¹¤Î­¹«~¥]§÷¤§¦w¥þ©ÊÀ³¥[¥H­«µø¡C

¤G¡BÀô¹Ò²üº¸»X

(¤@)Àô¹Ò²üº¸»X¤§ºØÃþ

¬ü°ê¬F©²©ó1966¦~­º¥ý´£¥X·|¤zÂZ¥Íª«Å餺¤Àªc¨t²Î¤§¤Æ¾Çª«½è¡A¥²¶·¥[¥HºÞ¨î¡A¨Ã­q©w¿z¿ï­ì«h¤Î´ú¸Õ½d³ò¡F¥ì§Q¿Õ¦{Àô«O§½(Illinois EPA)´£¥X¥i¯à¼vÅT°Êª«¤Î¤HÅ餺¤Àªc¨t²Î¤§74ºØ¤Æ¾Çª«½èªì¨B¦W³æ¡F¤é¥»Àô¹ÒÆU«h©ó1988¦~¤½§G¨ãÀô¹Ò²üº¸»X®ÄÀ³¤§¤Æ¾Çª«½è70ºØ¡A¨ä¤¤¥]¬A±þÂξ¯¡B±þµß¾¯¡B°£¯ó¾¯¤Î¶ì¤Æ¾¯¡A¥H¤Î­«ª÷ÄÝ¡BÀ¹¶ø¨¯©M¬É­±¬¡©Ê¾¯µ¥(¤ýµ¥¡A2000)¡C

(¤G)Àô¹Ò²üº¸»X¤§§@¥Î¾÷¨î

¨Ì2000¦~·L¥Íª«»PÀô¹Ò²üº¸»X¬ã°Q·|½×¤å¶°¤¤¡A¡u¥xÆW¦a°ÏºÃ¦üÀô¹Ò²üº¸»Xª«½èºÞ²z¤ÎÀô¹Ò¬y¥¬½Õ¬d¡v¤@¤å¡AÀô¹Ò²üº¸»X¤Æ¾Çª«½è¹ï¤º¤Àªc¨t²Î¤§¤zÂZ¾÷¨î¥i¤À¬°¡G

1.¤Æ¾Çª«½è¤§µ²ºcÃþ¦ü©ó»Û©Ê°Ê±¡¿E¯À(estrogen)¡A·í¨ä¶i¤J°Êª«Åé²Ó­M¤º¡A»P»Û©Ê¿E¯À¨üÅé³J¥Õµ²¦X¦Ó»¤µo¬Û¦P¤§¥Í²z¥\¯à¡A²£¥Í°²©Ê²üº¸»X§@¥Î¡F¦p¤Ð°ò­f×ô¤ÎÂù×ôA(bisphenol A)µ¥¤Æ¾Çª«½è§¡Äݦ¹Ãþ¡C

2.¤Æ¾Çª«½è»P°Êª«Å餺¶¯©Ê¿E¯À¨üÅé³J¥Õµ²¦X¡A¦û¾Ú¤F­ì¨üÅéµ²¦X¦ì¸m¡A¨Ï¥¿±`¶¯©Ê¿E¯À²üº¸»XµLªk»P¨üÅé³J¥Õµ²¦X¡A¦]¦Ó§í¨î¤F¶¯©Ê¿E¯Àªº§@¥Î¡A¶i¦ÓªýÂ_¥¿±`¥Í²z¥\¯à¡F¦p±þÂξ¯(DDT)ªº¥NÁª«DDE§Y¨ã¦³§í¨î¶¯©Ê©Ê¼x¡A¦Ó¥X²{»Û©Ê©Ê¼x¤§®ÄÀ³¡C

3.¤Æ¾Çª«½è»P²Ó­M¤º¨ä¥L¨üÅé³J¥Õ½èµ²¦X¡A¬¡¤Æ¿ò¶Çª«½è¡A²£¥Í¥\¯à³J¥Õ¡F¶¡±µ¼vÅT¶¯©Ê¿E¯À¤§¥\¯àªÌ¡A¦pDioxin§Y¨ã¦³¦¹®ÄÀ³¡C

¤T¡BÀô¹Ò¤¤¤Ð°ò­f×ôªº¨Ó·½»P¤HÅé¼ÉÅS

(¤@)Àô¹Ò¤¤¨Ó·½»P­°¸Ñ

¦b¤Ð°ò­f×ô­l¥Íª«¤§¨Ï¥Î¤W¡A³Ì¤j©v¬°¡u¤Ð°ò­f×ô»E¤A®ñ°ò¾JÃþ(NPnEO)¡v¤§»s³y¡CNPnEO¬°¥Ø«e¨Ï¥Î³Ì¼sªxªº«DÂ÷¤l¬É­±¬¡©Ê¾¯¡A¨Ï¥Î²v¹F80% (¤ýµ¥¡A2000)¡C¦]¦¹NPnEOªº¨Ï¥Î¬°Àô¹Ò¤¤¤Ð°ò­f×ô¦Ã¬V¤§¥D­n¨Ó·½¡A¨ä¥L¹³¾ð¯×¡B¶ì½¦»s«~¤§¨Ï¥Î¡A¥ç¬°¤Ð°ò­f×ô¤§¦Ã¬V¨Ó·½¡CNPnEO¤§¥Íª«¤À¸Ñ³~®|(Ahel et al., 1993)¡G

1.NPnEO¤§³Ìªì¤À¸Ñ«Ü®e©öµo¥Í¡A¦ý¬O³Ì²×¨Ã¤£®e©ö§¹¥þ¤À¸Ñ¡C

2.¦b¬¡©Ê¦Ãªd³B²z¼t¡ANPnEO¥Íª«­°¸Ñ²£ª«¬Ocarboxylated NPnEO¡F¦b¹½®ñÀô¹Ò¤U¡A³Ì­«­nªº­°¸Ñ²£ª«¬O¤Ð°ò­f×ô¡C

3.¦b¹½®ñÀô¹Ò¤U¡A¤Ð°ò­f×ô«Ü¤£®e©öÄ~Äò­°¸Ñ¡C

 (¤G)¤Ð°ò­f×ô§@¬°²K¥[¾¯

²{¦æ¥«°â¤§¤Æ¾Ç¦X¦¨²M¼ä¾¯¡A¨Ì¨ä¥h¦Ã­ì²z¡A¥i·§¤À¬°¶§Â÷¤l¬É­±¬¡©Ê¾¯¡B³±Â÷¤l¬É­±¬¡©Ê¾¯¡B¨â©Ê¬É­±¬¡©Ê¾¯¡B«DÂ÷¤l¬É­±¬¡©Ê¾¯µ¥ºØÃþ¡F¨ä¤¤¥H³±Â÷¤l¬É­±¬¡©Ê¾¯(70¢M)¤Î«DÂ÷¤l¬É­±¬¡©Ê¾¯(27.4¢M)¬°³Ì¤j©v¡C¦Ó¤Ð°ò­f×ô»E¤A®ñ°ò¾JÃþ¦û«DÂ÷¤l¬É­±¬¡©Ê¾¯¥«³õªº¤K¦¨¡A¬°¤u·~¬~º°¤Î¥h°£ªo¦Ã¤§¥D­n¦¨¥÷¡A¼s¥Î©ó²M¬~¤u·~¤Î¨Å¤Æ¤u·~¡C«DÂ÷¤l¬É­±¬¡©Ê¾¯¨Ï¥Î«á¦ô­p¬ù¦³35¢H¥H¤W±Æ©ñ©ó¤ôÅéÀô¹Ò¤¤(¤ýµ¥¡A2000)¡C¥t¥~¡A¶ì½¦¦b»s³y¡B¥[¤u©Î¨Ï¥Î¹Lµ{¤¤¡A±`¦]¼ö¡B¥ú¡B®ñ¡Bª÷ÄÝÂ÷¤l¤Î¾÷±ñ°Å¤Á¤Oµ¥ªº§@¥Î¦Ó²£¥Í¦Û¥Ñ°ò¡A¾É­P¶ì½¦®ñ¤Æµõ¸Ñ¡A¦Ó¨Ï¶ì½¦²£«~¥ú¿A«×­°§C¡BÅܦâ¡BÀtµõ¡B­éÂ÷¨Ã³y¦¨¶ì½¦­@½ÄÀ»±j«×¡B§Ü§é±j«×©M¦ù±i±j«×ªº­°§C¡A¬G¥²¶·²K¥[§Ü®ñ¤Æ¾¯¥H§í¨î¸ÓÃþ¤ÏÀ³¡C²Gª¬ªº¤T¤Ð°ò¨ÈÁC»Ä¯×(tris(nonylphenyl) phosphate, TNPP)¬°¦¸¯Å§Ü®ñ¤Æ¾¯¡A¬O³Ì±`°µ¬°¼ö¦w©w¾¯ªº¦@¦w©w¾¯(costabilizer)(¶À¡B¾G¡A2002)¡CHoweµ¥(2001)±´°Q¤Ð°ò­f×ô©ó¶ì½¦»E¦Xª«(»E­f¤A²m(Polystyrene¡APS)¡B§C±K«×»E¤A²m(low-density polyethylene¡ALDPE)¡B»E´â¤A²m(polyvinyl chloride¡APVC))¤§²K¥[¨Ï¥Î±¡§Î¡C¥t¥~¡A¤]¥iÀ³¥Î²K¥[©ó¨Å½¦º£¤¤§@¬°¨Å¤Æ¾¯(Inoue et al., 2001)¡A©Î¬O¥H¬É­±¬¡©Ê¾¯ªº§Î¦¡²K¥[©ó±þÂξ¯»P°£¯ó¾¯ªº°t¤è¤¤¡A¥H´£°ª±þÂξ¯Äa¯B©M¨Å¤Æ§@¥ÎªºÃ­©w©Ê(Seaman, 1990)¡C

(¤T)¤Ð°ò­f×ô¹ï¥Íª«Å餧¼vÅT

¥Ñ¥Ø«e¬ã¨sµo²{¡AÁöµM¤Ð°ò­f×ô¤§»Û¿E¯À¼ç¤O»·¤p©ó17£]-estradiol¡A¦ý«o¹ï¥Íª«¤§¤º¤Àªc¨t²Î³y¦¨¼vÅT¡C¤ýµ¥(2000)µo²{¡A¶¯ÃU³½¼ÉÅS©ó¤Ð°ò­f×ô¨â¶g«á¡A¨ä§Z¶À«e½è(vitellogenin¡AVtg)¿@«×©úÅã¼W¥[¡A¥|¶g«á¼W¬°ªÅ¥Õ¹ï·Ó²Õªº46­¿¡FFlouriot (1995)¦b¬ã¨s³ø§i«ü¥X¡A¤Ð°ò­f×ô¥i¥H¨ú¥N»Û©Ê¿E¯À(17£\-ethinylestradiol¡AEE2)¡A¨Ã©TµÛ©ó¨xŦ»Û¿E¯À¨üÅé(estrogen receptor¡AER)¾É­P§Z¶À«e½è¤§²Ö¿n¡C¦Ó¨Ì¾ÚLee (1998)¬ã¨sµo²{¡A¼ÉÅS©ó¤Ð°ò­f×ô¤§¶¯©Ê¥®¹«¡A¨ä¸A¤Y¡B°Æ¸A¡BºëÅn¡BÄáÅ@¸¢§¡´î¤p¡A¥B±wÁô¸A¯g(cryptorchidism)ÀW²v¦³¼W¥[¤§ÁͶաF¥t¥~¡AChapinµ¥(1999)¬ã¨s«ü¥X¤Ð°ò­f×ô·|¨ÏÅ餺¤§»Û¿E¯À¬¡©Ê¼W±j¡A¥[³t³±¹D¶}¤f(accelerated vaginal opening)¡B°Ê±¡¶g´Á¥Ë¸Ñ(estrous cycle disruption)¡A¥ç·|§ïÅܵÇŦµ²ºc»P­«¶q¡CYadetie (1999)¥H¤Ð°ò­f×ôª½±µ¼ÒÀÀÂD³½¨xŦ¤§»Û¿E¯À»P»Û¿E¯À¨üÅéµ²¦X¸ÕÅç¡Aµo²{³½Åé¤Àªc¥X§Z¶À«e½è¤Î³J¥Õ¼h¡CBaker (2001)¦b¬ã¨s¤¤µý¹ê¤Ð°ò­f×ô·|­°§C¶¯©Êªº¥Í´Þ¯à¤O¤Î·l®`°·±d¡C­^°ê±N¤Ð°ò­f×ô¹ï³½ÃþªºµLÅãµÛ¼vÅT¿@«×¡]No observation effect concentration, NOEC¡^­q¬°10 £gg/L¡A¤é¥»«h­q¬°6.08 £gg/L¡A¨Ã¨ú¨ä1/10¡]§Y0.608£gg/L¡^¬°¹w¦ôµLÅãµÛ¼vÅT¿@«×¡]Predicted no effect concentration¡APNEC¡^¡C¶¯³½¦b¤ô¤¤¤Ð°ò­f×ô¿@«×23.5£gg/L ®É·|¥X²{¤G¦¸©Ê¼x¤§»Û¤Æ¡A¦b11.6£gg/L ®É¥X²{ºë±_§Z(¤ýµ¥¡A2000)¡F¼Ú·ù­qPNEC¬°0.7£gg/L (§d¡B¤B¡A2000)¡CCunnyµ¥(1997)¥H90¤Ñ­«´_¾¯¶q¨ÈºC©Ê¬r©Ê¸ÕÅç(subchronic toxicity test)»{¬°µL¬r©ÊÅã¥Ü¾¯¶q(No observed adverse effect level¡ANOAEL)À³¬° 50 mg/kg/day¡CChapinµ¥(1999)¬ã¨s»{¬°¤Ð°ò­f×ô¹ï¤j¹«¤§¥Í´Þ¨t²ÎNOAEL¬°200 ppm¡C

(¥|)¤Ð°ò­f×ô¹ï¤HÅ餧¼vÅT

¹ï¤HÃþ¦Ó¨¥¡A¤Ð°ò­f×ô·|¨Ï¸A¤YµLªk¤Àªc¨¬¶qªº¸A©Tà¬(testosterone)¡A¦Ó¾É­P¸A¤Y¥¼­°(undescended testis)¡B§¿¹D¤Uµõ(hypospadias)¡A¬Æ¦Ü¤Þµo¸A¤YÀù(carcinoma in situ testis)¡C¥ç·|´£°ª«e¦C¸¢Àùªº¿©±w²v¡A¹ï¨k©Ê¥Í´Þ¨t²Î¤Î°·±d³y¦¨«Â¯Ù(Paganetto et al., 2000)¡C¥Ñ©ó¤Ð°ò­f×ô¬OÀô¹Ò¤¤NPnEO¤§·L¥Íª«­°¸Ñ²£ª«¡A¥D­n¬O¸g¥Ñ¶¼­¹¦Ó¶i¤J¤HÅé¡A¨ä¥L¤HÅé¼ÉÅS³~³wÁÙ¥]¬A¡GªÅ®ð§l¤J¡B¥Ö½§§l¦¬©Î¨Ï¥ÎÂåÀøPVC¾¹§÷ª`®g¶i¤J¤HÅé(Inoue et al., 2001)¡CMullerµ¥(1998)¬ã¨sÅã¥Ü¡A«D¾·~¼ÉÅS±Ú¸s¦¨¤H¤Ð°ò­f×ô¨C¤é³Ì¤jÄá¤J¶qÀ³¤p©ó0.16 mg/day¡C

¥|¡B­¹«~¤Î­¹«~¥]¸Ë§÷½è¤§¦w¥þ©Ê

¥Ñ©ó¦h¼ÆªºÀô¹Ò²üº¸»Xµ¥¤Æ¾Çª«½èÂǥѺغتº³~®|´Ý¯d©óÀô¹Ò¡B­¹ª«¤Î¤é±`¥Í¬¡¥Î¨ã¤¤¡A¹ï¤HÃþ¦Ó¨¥¡A¶¼­¹¬O³Ìª½±µ¼ÉÅS©ó³o¨Ç¤Æ¾Çª«½èªº­«­n³~®|¡C¯S§O¦b¥xÆW³o­Ó¦ì©ó¨È¼ö±aªº®ü®q«¬°ê®a¡A¤ô²£¸ê·½¬Û·íÂ×´I¡A¤]¬O°ê¤H¶¼­¹·í¤¤¤£¥i©Î¯Êªº³¡¥÷¡A¥xÆW¦U¦a°Ï¤§¤ô²£«~¬O§_¾D¨ì¦¹Ãþª«½è¤§¦Ã¬V¡A¬O¤@­È±o¥[¥H­«µø¤§°ÝÃD¡C¥t¥~¡A¥Ñ©ó¤u°Ó·~¤§µo¹F¥Í¬¡¦£¸L¡A°ê¤H¥~­¹¤ñ¨Ò«Ü°ª¡A¹ï©ó¥~­¹À\¨ã¤Î¦UºØ­¹«~¥]¸Ë§÷®Æªº¨Ï¥ÎÀWÁc¡C¦UºØ¾¹¨ã¤Î¥]§÷¥i¯à¦³¤Ð°ò­f×ô¤Æ¦Xª«·»¥X¡A¦]¦¹¡A¨ä¨Ï¥Î¤§¦w¥þ©Ê¥ç­È±o­«µø¡C

¦³Å²©ó¦¹¡A¥»¬ã¨s«Ç´¿¹ï¥«°â­¹«~¤Î¨ä¥]¸Ë§÷®Æ©â¼Ë¤ÀªR¤Ð°ò­f×ô§t¶q¡Aµ²ªGµo²{¥«°â­¹«~¼Ë«~¤¤¦³¤Ö¼Æ¥iÀË¥X·¥·L¶q¤Ð°ò­f×ô¡C¥t¥~¡A°w¹ï¯ÈÃþÀ\¨ã¡B¾Tºä¥]¸Ë(Tetra Pak)¡B»E­f¤A²m(PS)¡B»E¤A²m(PE)¡B»E¤þ²m(PP)¡B»EºÒ»Äà­(PC)¤ÎÅKÅø¶i¦æ¤Ð°ò­f×ô·»¥X¶q¤§¤ÀªR¡Cµ²ªGµo²{¤Ö¼Æ­¹«~¥]§÷¤Î®e¾¹·|·»¥X·¥·L¶q¤Ð°ò­f×ô¡C­¹«~¤Î­¹«~¥]¸Ë§÷®Æªº¤Ð°ò­f×ôÄÀ¥X¶q¡A¬Ò»·§C©óNagaoµ¥(2001)¤§¬ã¨sµ²ªG»{¬°¤Ð°ò­f×ôµL¬r©ÊÅã¥Ü¾¯¶q¬°10 mg/day¡C¬G³o¨Ç§÷½èªº¨Ï¥Î²z½×¤W¬O¦w¥þªº¡F¨}¦nªº­¹«~®e¾¹¬O«Ø¥ß¦b®ø¶OªÌªº¥¿½T¨Ï¥Î¤èªk¤W¡A¥ô¦ó­¹«~®e¾¹¦h¤Ö³£¦s¦b¤£¦Pªº­·ÀI¡A«Øij®ø¶OªÌ¡A¦b¤@¯ë«D¯S©wªº±¡§Î¤U¡A³Ì¦nªº®e¾¹ÁÙ¬O¥H°ª«~½èªº¤£ù׿û¡B³³²¡¾¹¬°¥D(¤×¨ä¬O¥¼¤W«Ü¦h¹V®Æ©Î«D±m¦âªº³³²¡¾¹)»P¬Á¼þ®e¾¹¡A³o¨Ç®e¾¹¬Û¹ïªº¦w¥þ³\¦h¡C¬JµM¤w¸gª¾¹D³o¨Ç­¹«~®e¾¹ªº¦w¥þ©Ê¡A´î¤Ö¨Ï¥Î©öÄÀ¥X¤Æ¾Çª«½èªº¶ì½¦¥]¸Ë§÷®Æ¡A¤~¯à­°§C°·±d­·ÀI¡C

¤­¡Bµ²½×

§Ú°êÖJ°ò×ôÃþ«DÂ÷¤l«¬¬É­±¬¡©Ê¾¯¤§¦~¨Ï¥Î¶q°ª¹F48,000¤½¾·(¤ýµ¥¡A2000)¡A³o¨Ç§t¤Ð°ò­f×ô¤Æ¾Çª«½è¨Ï¥Î«á¥i¯àÀHµÛ®a®x¦Ã¤ô¡B¥«¬F¼o¤ô©Î¤u·~¼o¤ô¦Ó±Æ©ñ©óÀô¹Ò¤¤¡C«ØijÀô¹Ò«OÅ@³æ¦ì¹ï¸ÓÃþª«½è¤§¨Ï¥Î°µ¬ÛÃö³W©w©Î­­¨î¡A¨Ã¼W¥[¦Ã¤ô³B²z¼t¤§³]¸m¤Î¦Ã¤ô³B²z®Ä²v¡AÁקK¦¾¤ôª½±µ±Æ¤JÀô¹Ò¤¤¡C¥t¥~¡A­¹«~¥]§÷¤]¬O¤Ð°ò­f×ô¶i¤J¤HÅé³~®|¤§£¸¡AÁöµMºÃ¦üÀô¹Ò²üº¸»X¤Æ¾Çª«½è¤w¦³¬ÛÃöªk³W¶}©l¦CºÞ¡A¦ý¦b­¹«~¥]¸Ë§÷½è¤¤©Ò§t¤Ð°ò­f×ôª«½è¤§²K¥[¾¯ªº¨Ï¥Î¶q¡A¥H¤Î¤Ð°ò­f×ôª«½è·»¥X¤§ÀËÅç¼Ð·Ç¡A»Ý¬ÛÃö½Ã¥Í³æ¦ì¨î©w¤@®M¥i¨Ñ¨Ï¥Îªº³W½d¡BÀËÅç¼Ð·Ç¤Î­·ÀIµû¦ô¡A¥H½T«O¼s¤j®ø¶OªÌ¤§¨Ï¥Î¦w¥þ¡C¦b¦¹¡A©IÆ~ªÀ·|¤j²³¤Î¬ÛÃö³æ¦ìÀ³­«µøÀô¹Ò¦¾¬V¤§°ÝÃD¡A¡yÀô¹Ò¢w­¹«~¢w°·±d¡z¤§½ÒÃD­È±o¤j®aÃö¤ß¡C

¤»¡B°Ñ¦Ò¤åÄm

1.¤ý¥¿¶¯¡B±i¤pµÓ¡B§õ©y¾ì¡B¶À¥ôºÀ¡B³¯¨Ø¬À¡B¬x¤å©v¡G¥xÆW¦a°ÏÀÀ¦üÀô¹Ò²üº¸»Xª«½èºÞ²z¤ÎÀô¹Ò¬y§G½Õ¬d¡C·L¥Íª«»PÀô¹Ò²üº¸»X¬ã°Q·|½×¤å¶°¡A1-25 (2000)¡C

2.§d«Ø©y¡B¤B±æ½å¡GÀô¹Ò²üº¸»X-¤Ð°ò­f×ô»PÂù×ôA¦b»OÆW¤ôÀô¹Ò¤¤¤§¤À¥¬»P¬y¥¬½Õ¬d¡CÀô¹ÒÀËÅç³q°TÂø»x¡A33: 12-21 (2000)¡C

3.¶À¯À¯u¡B¾G¼w¤§¡G¶ì½¦²K¥[¾¯¥«³õ²{ªp»P¥¼¨Óµo®iÁͶաC¤Æ¤u¬ì§Þ»P°Ó±¡¡A38¡G 67-70 (2002)¡C

4.Ahel M, Mcevoy J, Giger W: Bioaccumulation of the lipophilic metabolites of nonionic surfactants in Fresh-water organisms. Environ. Pollut., 79: 243-248 (1993).

5.Chapin RE, Delaney J, Wang Y, Lanning L, Davis B, Collins B, Mintz N, Wolfe G: The effects of 4-nonylphenol in rats: a multigeneration reproduction study. Toxicological Science, 52: 80-91 (1999).

6.Cunny HC,  Mayes BA,  Rosica KA, Trutter JA,  Van Miller JP: Subchronic Toxicity (90-Day) Study with para-Nonylphenol in Rats. Regulatory Toxicology and Pharmacology, 26: 172-178 (1997).

7.Ding WH, Tzing SH: Analysis of nonylphenol polyethoxylates and their degradation products in river water and sewage effluent by gas chromatography-ion trap (tandem) mass spectrometry with electron impact and chemical ionization. J. Chromatogr. A, 824: 79-90 (1998).

8.Franke C, Studinger G, Berger G, Böhling S, Bruckmann U, Dieter CF, Jöhncke U: The assessment of bioaccumulation.  Chemosphere, 29(7): 1501-1514 (1994).

9.Guenther K, Heinke V, Thiel B, Kleist E, Prast H, Raecker T: Endocrine disrupting nonylphenols are ubiquitous in food. Environ. Sci. Technol., 36: 1676-1680 (2002).

10.Gilbert J, Startin JR, McGuinness JD: Compositional analysis of commercial PVC bottles and studies of aspects of specific and overall migration into foods and stimulants. Food Add. Contam., 3: 133-143 (1986).

11.Howe SR, Surana P, Jakupea MR, Borodinsky L: Potential dietary exposure to p-nonylphenol from food-contact use of tris(nonylphenol)phosphate (TNPP). Food Add. Contam., 18: 1021-1039 (2001).

12.Inoue K, Kondo S, Yoshie Y, Kato K, Yoshimura Y, Horie M, Nakazawa H: Migration of 4-nonylphenol from polyvinyl chloride food packaging films into food simulants and foods. Food Add. Contam., 18: 157-164 (2001).

13.Jobling S, Nolan M, Tyler CR, Brighty G, Sumpter JP: Widespread sexual disruption in wild fish. Environ. Sci. Technol., 32: 2498-2506 (1998).

14.Lee PC: Testicular abnormalities in male rats after lactational exposure to nonylphenols. Endocrine., 9: 105-111 (1998).

15.Seaman D: Trends in the formulation of pesticide-an overview. Pestic. Sci., 29: 437-449 (1990).

16.Sharpe RM, Fisher JS, Millar MM, Jobling S, Sumptwe JP: Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect., 103: 1136-1143 (1995).